A cohort study of more than 3,000 persons who received hydroxychloroquine for 5 or more years with guideline-recommended serial retinopathy screening found that the overall risk for incident ...

Please provide your email address to receive an email when new articles are posted on . Hydroxychloroquine dosing averages in patients with lupus fall in line with AAO-prescribed standards. The rate ...

Please provide your email address to receive an email when new articles are posted on . The risk for hydroxychloroquine retinopathy increases with higher dosing per actual and ideal body weight, and ...

Older patients prescribed hydroxychloroquine (HCQ) have a higher risk of developing retinal damage from taking the medication, according to a new analysis. In addition to known risk factors such as a ...

A new study likely makes the best estimate yet of the degree of retinopathy risk that patients who take the antimalarial drug hydroxychloroquine (HCQ) can expect, deriving mainly from the cumulative ...

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that higher doses, longer duration of use, chronic kidney disease and Asian race could ...

Increased risk seen in association with female sex, older age, CKD stage 3 or greater, tamoxifen use. HealthDay News — Factors associated with an increased risk for hydroxychloroquine retinopathy have ...

Retinal damage from taking hydroxychloroquine (HCQ) for more than 5 years occurred more frequently among people with certain characteristics, records from nearly 5,000 patients in the Kaiser ...

The risk for HCQ-associated retinopathy increases over time among patients with rheumatic diseases, particularly at higher doses and with prolonged exposure.

Did you know that hydroxychloroquine, or Plaquinil, is a medication often used to treat lupus, but its side effects can cause sight issues? Dr. Michelle Petri, founder and director of Johns Hopkins ...